Erin Dunnigan Roe, MD
Endocrinology, Diabetes & Metabolism Physician · Dallas, TX
Erin Dunnigan Roe, MD is an endocrinology, diabetes & metabolism physician with a practice address in Dallas, Texas, and NPI 1174726590, issued on Jun 6, 2007. Check the license (Texas N7080, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Erin Dunnigan Roe
- Credential
- MD
- Primary taxonomy
- Endocrinology, Diabetes & Metabolism Physician 207RE0101X
- License number
- N7080 TX
Self-reported in NPPES; status is on the state search - Practice location
- 3600 Gaston Ave, Dallas, TX 75246
- Phone
- (214) 820-3466
- Enumerated
- Jun 6, 2007
- Record last updated
- Dec 3, 2012 (not updated in 14 years: call before relying on the address or phone)
- Fax
- (214) 820-3468
- Entity
- Type 1 · individual
8 nearest endocrinology, diabetes & metabolism physician records → All 743 in Texas → Look up another NPI →
Also registered at 3600 Gaston Ave
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Carol Adair, M.D.Anatomic Pathology Physician1790756369
- Paul Aggarwal, MDCardiovascular Disease Physician1740228063
- Ashley Agura, PA-CMedical Physician Assistant1871988519
- Abrar Ahmad, MDHospitalist Physician1346270634
- Tanveer Ahmed, MDCritical Care Medicine (Internal Medicine) Physician1265491724
- Lisette Alfaro-Berg, MDHospitalist Physician1437189727
Verify Erin Dunnigan Roe in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license N7080Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
95% fewer Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024
133 Medicare Part D claims for 14 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 62% of claims.
Most prescribed
- Mounjaro18 claims
- Lantus Solostar11 claims
- Metformin Hcl11 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $310.04
21 payments; by number, the most common kind was food and beverage; the largest payer was Mannkind Corporation. The 5,661 providers of this specialty with any payment received $5,742.15 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Erin Dunnigan Roe among 743 endocrinology, diabetes & metabolism physician records in Texas
Erin Dunnigan Roe, MD is one of 743 endocrinology, diabetes & metabolism physician records with a practice address in Texas. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2007, is newer than 39% of them.
- NPI issued2007 · 39% of these records are older, 48% newer
- In a Medicare fileYes · 87% of these records are
- In the CMS Doctors and Clinicians fileNo · 75% of these records are
- Record last updated2012 · 50% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Endocrinology, Diabetes & Metabolism Physician providers in Texas
There are 743 endocrinology, diabetes & metabolism physician records in Texas.
All 743 in Texas → Every provider in Dallas → Endocrinology, Diabetes & Metabolism Physician nationwide →
The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes
- Ajikumar Aryangat, M.D.Dallas, TX 752461407971856
- Howard Heller, MDDallas, TX 752461538129424
- Priscilla Hollander, PH.D, M.D.Dallas, TX 752461417988098
- Minh-Da LeDallas, TX 752461336502749
- Lipi Marion, MDDallas, TX 752461407319981
- Samuel Marynick, M.D.Dallas, TX 752461801854187
- Alok Mohan, MDDallas, TX 752461841240355
- Rebecca Short, M.D.Dallas, TX 752461932542776
Common questions
What is Erin Dunnigan Roe, MD's NPI number?
Erin Dunnigan Roe, MD's National Provider Identifier (NPI) is 1174726590, issued on Jun 6, 2007. An NPI identifies a provider in billing; it is not a license.
Where is Erin Dunnigan Roe, MD located?
The NPPES record lists a practice address at 3600 Gaston Ave, Dallas, TX, 75246. Phone: (214) 820-3466. Providers update this record themselves, so call before visiting.
How can I verify Erin Dunnigan Roe, MD's license?
NPPES lists Texas license number N7080, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Erin Dunnigan Roe, MD prescribe under Medicare Part D?
In 2024, Erin Dunnigan Roe, MD had 133 Medicare Part D claims for 14 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.